Matches in Wikidata for { <http://www.wikidata.org/entity/Q85061787> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q85061787 description "article scientifique publié en 2011" @default.
- Q85061787 description "artículu científicu espublizáu en xunu de 2011" @default.
- Q85061787 description "im Juni 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q85061787 description "scientific article published on 28 June 2011" @default.
- Q85061787 description "wetenschappelijk artikel" @default.
- Q85061787 description "наукова стаття, опублікована в червні 2011" @default.
- Q85061787 name "Effects of combination therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein (≥ 2 mg/L). cmb@bcm.tmc.edu" @default.
- Q85061787 name "Effects of combination therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein (≥ 2 mg/L). cmb@bcm.tmc.edu" @default.
- Q85061787 type Item @default.
- Q85061787 label "Effects of combination therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein (≥ 2 mg/L). cmb@bcm.tmc.edu" @default.
- Q85061787 label "Effects of combination therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein (≥ 2 mg/L). cmb@bcm.tmc.edu" @default.
- Q85061787 prefLabel "Effects of combination therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein (≥ 2 mg/L). cmb@bcm.tmc.edu" @default.
- Q85061787 prefLabel "Effects of combination therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein (≥ 2 mg/L). cmb@bcm.tmc.edu" @default.
- Q85061787 P1433 Q85061787-9AEB5728-B7A1-4EF5-9E67-C1FD9DCD3909 @default.
- Q85061787 P1476 Q85061787-B66EE424-6642-42A7-9658-40BA87D95F3C @default.
- Q85061787 P2093 Q85061787-41EFB0B2-47ED-48ED-8692-427F420151DD @default.
- Q85061787 P2093 Q85061787-52C109B8-1567-4A00-8F11-AC259A9D05A4 @default.
- Q85061787 P2093 Q85061787-A1952959-B866-45CD-958A-12D74B82EA23 @default.
- Q85061787 P304 Q85061787-CF60969B-373E-4664-9E6B-A3C6E996347F @default.
- Q85061787 P31 Q85061787-B577533B-5DD5-420B-AAE2-820104E59050 @default.
- Q85061787 P356 Q85061787-DBE13A75-F64D-4DC6-88B8-74084B0D0029 @default.
- Q85061787 P433 Q85061787-E6C49C61-D943-4501-BE05-F54B24466BB0 @default.
- Q85061787 P478 Q85061787-05F1DCE0-D258-4406-862E-5AC615A3454B @default.
- Q85061787 P50 Q85061787-A0224420-CF68-4C15-B412-28F08158164F @default.
- Q85061787 P577 Q85061787-0D08DBF4-3ED4-4F11-93C2-CCFC6E27AC77 @default.
- Q85061787 P698 Q85061787-6B00719F-8E44-4376-8837-7FF28F0C6818 @default.
- Q85061787 P921 Q85061787-CC5E9B3B-BCE1-46B0-AC6B-30BE7BE4982C @default.
- Q85061787 P356 J.JACL.2011.06.010 @default.
- Q85061787 P698 21981842 @default.
- Q85061787 P1433 Q15817174 @default.
- Q85061787 P1476 "Effects of combination therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein (≥ 2 mg/L). cmb@bcm.tmc.edu" @default.
- Q85061787 P2093 "Carolyn M Setze" @default.
- Q85061787 P2093 "Maureen T Kelly" @default.
- Q85061787 P2093 "Michael H Davidson" @default.
- Q85061787 P304 "401-407" @default.
- Q85061787 P31 Q13442814 @default.
- Q85061787 P356 "10.1016/J.JACL.2011.06.010" @default.
- Q85061787 P433 "5" @default.
- Q85061787 P478 "5" @default.
- Q85061787 P50 Q98665268 @default.
- Q85061787 P577 "2011-06-28T00:00:00Z" @default.
- Q85061787 P698 "21981842" @default.
- Q85061787 P921 Q66291209 @default.